AAAAAA
Results:
1-7
|
Results: 7
Authors:
Keidar, S
Heinrich, R
Kaplan, M
Hayek, T
Aviram, M
Citation: S. Keidar et al., Angiotensin II administration to atherosclerotic mice increases macrophageuptake of oxidized LDL - A possible role for interleukin-6, ART THROM V, 21(9), 2001, pp. 1464-1469
Authors:
Keidar, S
Pappo, I
Shperber, Y
Orda, R
Citation: S. Keidar et al., Cecal diverticulitis: A diagnostic challenge, DIGEST SURG, 17(5), 2000, pp. 508-512
Authors:
Keidar, S
Attias, J
Coleman, R
Wirth, J
Scholkens, B
Hayek, T
Citation: S. Keidar et al., Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin, J CARDIO PH, 35(1), 2000, pp. 64-72
Authors:
Rosen, D
Li, JH
Keidar, S
Markon, I
Orda, R
Berke, G
Citation: D. Rosen et al., Tumor immunity in perforin-deficient mice: A role for CD95 (Fas/APO-1), J IMMUNOL, 164(6), 2000, pp. 3229-3235
Authors:
Hayek, T
Aviram, M
Heinrich, R
Sakhnini, E
Keidar, S
Citation: T. Hayek et al., Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients, BIOC BIOP R, 273(2), 2000, pp. 417-420
Authors:
Keidar, S
Attias, J
Heinrich, R
Coleman, R
Aviram, M
Citation: S. Keidar et al., Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis, ATHEROSCLER, 146(2), 1999, pp. 249-257
Authors:
Hayek, T
Attias, J
Coleman, R
Brodsky, S
Smith, J
Breslow, JL
Keidar, S
Citation: T. Hayek et al., The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice, CARDIO RES, 44(3), 1999, pp. 579-587
Risultati:
1-7
|